Mckesson Medical-Surgical Inc. Corporate Office: Drug Recall

Recall #D-1319-2022 · 06/29/2022

Class II: Risk

Recall Details

Recall Number
D-1319-2022
Classification
Class II
Product Type
Drug
Recalling Firm
Mckesson Medical-Surgical Inc. Corporate Office
Status
Terminated
Date Initiated
06/29/2022
Location
Richmond, VA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
67 bottles

Reason for Recall

CGMP Deviations: products were stored outside the drug label specifications.

Product Description

Miralax (Polyethylene Glycol 3350), Powder for Solution, Osmotic Laxative, 30 Once-Daily Doses, Net WT 17.9 OZ (510 g) bottle, Bayer Healthcare Pharmaceuticals, NDC 11523-7234-4.

Distribution Pattern

Nationwide in the USA.

Other Recalls by Mckesson Medical-Surgical Inc. Corporate Office

View all recalls by Mckesson Medical-Surgical Inc. Corporate Office →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.